Jump to content

User:Artour2006/Prevalence of hyperventilation

From Wikipedia, the free encyclopedia

Prevalence of hyperventilation[edit]

Minute ventilation or respiratory minute volume is the volume of air which is inhaled (inhaled minute volume) or exhaled (exhaled minute volume) from a person's lungs in one minute. Medical evidence suggests that hyperventilation is a common clinical findings for a variety of chronic health problems.

Condition Minute ventilation (± standard deviation) Number of patients Reference
Normal breathing 6 l/min None Medical textbooks: [1] [2] [3] [4]
Healthy Subjects 6-7 l/min >400 [5] [6] [7] [8] [9][10][11] [12]

[13] [14] [15] [16] [17] [18]

Normal Subjects 9-17 l/min >400 [19] [20] [21] [22] [23] [24] [25] [26]

[27] [28] [29] [30] [31] [32] [33]

Asthma 12 l/min 101 [34]
Asthma 15 l/min 8 [35]
Asthma 14.1 (±5.7) l/min 39 [27]
Asthma 13 (±4) l/min 17 [36]
Asthma 13 (±2) l/min 16 [37]
COPD 14 (±2) l/min 12 [38]
COPD 12 (±2) l/min 10 [39]
COPD 14 l/min 3 [40]
Heart disease 14 (±4) l/min 88 [21]
Heart disease 12.2 (±3.3) l/min 132 [41]
Heart disease 16 (±2) l/min 11 [42]
Heart disease 15 (±4) l/min 22 [43]
Heart disease 16 (±2) l/min 11 [44]
Heart disease 15 (±4) l/min 55 [23]
Heart disease 13 (±4) l/min 15 [45]
Heart disease 14 (±2) l/min 30 [46]
Heart disease 16 (±6) l/min 20 [47]
Pulm hypertension 12 (±2) l/min 11 [48]
Diabetes 10-20 l/min 28 [25]
Diabetes 12-17 l/min 26 [49]
Diabetes 15 (±2) l/min 45 [29]
Diabetes 12 (±2) l/min 8 [15]
Diabetes 13 (±2) l/min 20 [22]
Cystic fibrosis 11-14 l/min 6 [50]
Cystic fibrosis 13 (±1.8) l/min 10 [13]
Cystic fibrosis 15 L/min 15 [13]
Cystic fibrosis 10 L/min 11 [51]
Cystic fibrosis 10 L/min 10 [52]
Cystic fibrosis 16 L/min 7 [53]
Cystic fibrosis 18 L/min 9 [54]
Cancer 12 (±2) l/min 40 [33]
Sleep apnea 15 (±3) l/min 20 [55]
Liver cirrhosis 11-18 l/min 24 [26]
Hyperthyroidism 14.9 (±0.6) l/min 42 [56]
Epilepsy 12.8 l/min 12 [57]
Panic disorder 12 (±5) l/min 12 [58]
CHV 13 (±2) l/min 134 [24]
Bipolar disorder 11 (±2) l/min 16 [59]
Dystrophia myotonica 16 (±4) l/min 12 [19]

(Source: www.normalbreathing.com) There are many more medical studies that found 100% prevalence of chronic hyperventilation in patients with various chronic diseases and modern normal subjects.

References[edit]

  1. ^ Ganong WF, Review of medical physiology, 15-th ed., 1995, Prentice Hall Int., London.
  2. ^ Guyton AC, Physiology of the human body, 6-th ed., 1984, Suanders College Publ., Philadelphia.
  3. ^ McArdle W.D., Katch F.I., Katch V.L., Essentials of exercise physiology (2-nd edition); Lippincott, Williams and Wilkins, London 2000.
  4. ^ Straub NC, Section V, The Respiratory System, in Physiology, eds. RM Berne & MN Levy, 4-th edition, Mosby, St. Louis, 1998.
  5. ^ Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW, Respiration during sleep in normal man, Thorax. 1982 Nov; 37(11): p.840-844.
  6. ^ Burki NK, Ventilatory effects of doxapram in conscious human subjects, Chest 1984 May; 85(5): p.600-604.
  7. ^ Smits P, Schouten J, Thien T, Respiratory stimulant effects of adenosine in man after caffeine and enprofylline, Br J Clin Pharmacol. 1987 Dec; 24(6): p.816-819.
  8. ^ Fuller RW, Maxwell DL, Conradson TB, Dixon CM, Barnes PJ, Circulatory and respiratory effects of infused adenosine in conscious man, Br J Clin Pharmacol 1987 Sep; 24(3): p.306-317.
  9. ^ Tanaka Y, Morikawa T, Honda Y, An assessment of nasal functions in control of breathing, J of Appl Physiol 1988, 65 (4); p.1520-1524.
  10. ^ Turley KR,McBride PJ, Wilmore LH, Resting metabolic rate measured after subjects spent the night at home vs at a clinic, Am J of Clin Nutr 1993, 58, p.141-144.
  11. ^ Bengtsson J, Bengtsson A, Stenqvist O, Bengtsson JP, Effects of hyperventilation on the inspiratory to end-tidal oxygen difference, British J of Anaesthesia 1994; 73: p. 140-144.
  12. ^ Sherman MS, Lang DM, Matityahu A, Campbell D, Theophylline improves measurements of respiratory muscle efficiency, Chest 1996 Dec; 110(6): p. 437-414.
  13. ^ a b c Bell SC, Saunders MJ, Elborn JS, Shale DJ, Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis, Thorax 1996 Feb; 51(2): 126-131. Cite error: The named reference "Bell" was defined multiple times with different content (see the help page).
  14. ^ Parreira VF, Delguste P, Jounieaux V, Aubert G, Dury M, Rodenstein DO, Effectiveness of controlled and spontaneous modes in nasal two-level positive pressure ventilation in awake and asleep normal subjects, Chest 1997 Nov 5; 112(5): p.1267-1277.
  15. ^ a b Mancini M, Filippelli M, Seghieri G, Iandelli I, Innocenti F, Duranti R, Scano G, Respiratory Muscle Function and Hypoxic Ventilatory Control in Patients With Type I Diabetes, Chest 1999; 115; p.1553-1562.
  16. ^ Pinna GD, Maestri R, La Rovere MT, Gobbi E, Fanfulla F, Effect of paced breathing on ventilatory and cardiovascular variability parameters during short-term investigations of autonomic function, Am J Physiol Heart Circ Physiol. 2006 Jan; 290(1): p.H424-433.
  17. ^ Pathak A, Velez-Roa S, Xhaët O, Najem B, van de Borne P, Dose-dependent effect of dobutamine on chemoreflex activity in healthy volunteers, Br J Clin Pharmacol. 2006 Sep; 62(3): p.272-279.
  18. ^ Gujic M, Houssière A, Xhaët O, Argacha JF, Denewet N, Noseda A, Jespers P, Melot C, Naeije R, van de Borne P, Does endothelin play a role in chemoreception during acute hypoxia in normal men? Chest. 2007 May; 131(5): p.1467-1472.
  19. ^ a b Clague JE, Carter J, Coakley J, Edwards RH, Calverley PM, Respiratory effort perception at rest and during carbon dioxide rebreathing in patients with dystrophia myotonica, Thorax 1994 Mar; 49(3): p.240-244.
  20. ^ Dahan A, van den Elsen MJ, Berkenbosch A, DeGoede J, Olievier IC, van Kleef JW, Halothane affects ventilatory afterdischarge in humans, Br J Anaesth 1995 May; 74(5): p.544-548.
  21. ^ a b Clark AL, Chua TP, Coats AJ, Anatomical dead space, ventilatory pattern, and exercise capacity in chronic heart failure, Br Heart J 1995 Oct; 74(4): 377-380.
  22. ^ a b Tantucci C, Bottini P, Dottorini ML, Puxeddu E, Casucci G, Scionti L, Sorbini CA, Ventilatory response to exercise in diabetic subjects with autonomic neuropathy, J Appl Physiol 1996, 81(5): p.1978–1986.
  23. ^ a b Clark AL, Volterrani M, Swan JW, Coats AJS, The increased ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology, Heart 1997; 77: p.138-146.
  24. ^ a b Han JN, Stegen K, Simkens K, Cauberghs M, Schepers R, Van den Bergh O, Clément J, Van de Woestijne KP, Unsteadiness of breathing in patients with hyperventilation syndrome and anxiety disorders, Eur Respir J 1997; 10: p. 167–176.
  25. ^ a b Tantucci C, Scionti L, Bottini P, Dottorini ML, Puxeddu E, Casucci G, Sorbini CA, Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients, Chest. 1997 Jul; 112(1): 145-153.
  26. ^ a b Epstein SK, Zilberberg MD; Facoby C, Ciubotaru RL, Kaplan LM, Response to symptom-limited exercise in patients with the hepatopulmonary syndrome, Chest 1998; 114; p. 736-741.
  27. ^ a b Bowler SD, Green A, Mitchell CA, Buteyko breathing techniques in asthma: a blinded randomised controlled trial, Med J of Australia 1998; 169: 575-578.
  28. ^ DeLorey DS, Babb TG, Progressive mechanical ventilatory constraints with aging, Am J Respir Crit Care Med 1999 Jul; 160(1): p.169-177.
  29. ^ a b Tantucci C, Bottini P, Fiorani C, Dottorini ML, Santeusanio F, Provinciali L, Sorbini CA, Casucci G, Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy, J Appl Physiol 2001, 90: p. 889–896.
  30. ^ Bell HJ, Feenstra W, Duffin J, The initial phase of exercise hyperpnoea in humans is depressed during a cognitive task, Experimental Physiology 2005 May; 90(3): p.357-365.
  31. ^ Narkiewicz K, van de Borne P, Montano N, Hering D, Kara T, Somers VK, Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men, Hypertension 2006 Jan; 47(1): p.51-55.
  32. ^ Ahuja D, Mateika JH, Diamond MP, Badr MS, Ventilatory sensitivity to carbon dioxide before and after episodic hypoxia in women treated with testosterone, J Appl Physiol. 2007 May; 102(5): p.1832-1838.
  33. ^ a b Travers J, Dudgeon DJ, Amjadi K, McBride I, Dillon K, Laveneziana P, Ofir D, Webb KA, O'Donnell DE, Mechanisms of exertional dyspnea in patients with cancer, J Appl Physiol 2008 Jan; 104(1): p.57-66.
  34. ^ McFadden ER & Lyons HA, Arterial-blood gases in asthma, The New Engl J of Med 1968 May 9, 278 (19): 1027-1032.
  35. ^ Johnson BD, Scanlon PD, Beck KC, Regulation of ventilatory capacity during exercise in asthmatics, J Appl Physiol. 1995 Sep; 79(3): 892-901.
  36. ^ Kassabian J, Miller KD, Lavietes MH, Respiratory center output and ventilatory timing in patients with acute airway (asthma) and alveolar (pneumonia) disease, Chest 1982 May; 81(5): p.536-543.
  37. ^ Chalupa DC, Morrow PE, Oberdörster G, Utell MJ, Frampton MW, Ultrafine particle deposition in subjects with asthma, Environmental Health Perspectives 2004 Jun; 112(8): p.879-882.
  38. ^ Palange P, Valli G, Onorati P, Antonucci R, Paoletti P, Rosato A, Manfredi F, Serra P, Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients, J Appl Physiol. 2004 Nov; 97(5): p.1637-1642.
  39. ^ Sinderby C, Spahija J, Beck J, Kaminski D, Yan S, Comtois N, Sliwinski P, Diaphragm activation during exercise in chronic obstructive pulmonary disease, Am J Respir Crit Care Med 2001 Jun; 163(7): 1637-1641.
  40. ^ Stulbarg MS, Winn WR, Kellett LE, Bilateral Carotid Body Resection for the Relief of Dyspnea in Severe Chronic Obstructive Pulmonary Disease, Chest 1989; 95 (5): p.1123-1128.
  41. ^ Fanfulla F, Mortara , Maestri R, Pinna GD, Bruschi C, Cobelli F, Rampulla C, The development of hyperventilation in patients with chronic heart failure and Cheyne-Stokes respiration, Chest 1998; 114; p. 1083-1090.
  42. ^ Johnson BD, Beck KC, Olson LJ, O'Malley KA, Allison TG, Squires RW, Gau GT, Ventilatory constraints during exercise in patients with chronic heart failure, Chest 2000 Feb; 117(2): 321-332.
  43. ^ Dimopoulou I, Tsintzas OK, Alivizatos PA, Tzelepis GE, Pattern of breathing during progressive exercise in chronic heart failure, Int J Cardiol. 2001 Dec; 81(2-3): 117-121.
  44. ^ Johnson BD, Beck KC, Olson LJ, O'Malley KA, Allison TG, Squires RW, Gau GT, Ventilatory constraints during exercise in patients with chronic heart failure, Chest 2000 Feb; 117(2): p. 321-332.
  45. ^ Banning AP, Lewis NP, Northridge DB, Elbom JS, Henderson AH, Perfusion/ventilation mismatch during exercise in chronic heart failure: an investigation of circulatory determinants, Br Heart J 1995; 74: p.27-33.
  46. ^ Buller NP, Poole-Wilson PA, Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure, Heart 1990; 63; p.281-283.
  47. ^ Elborn JS, Riley M, Stanford CF, Nicholls DP, The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure, Br J Clin Pharmacol. 1990 May; 29(5): p.519-524.
  48. ^ D'Alonzo GE, Gianotti LA, Pohil RL, Reagle RR, DuRee SL, Fuentes F, Dantzker DR, Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension, Chest 1987 Jul; 92(1): p.57-62.
  49. ^ Bottini P, Dottorini ML, M. Cordoni MC, Casucci G, Tantucci C, Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy, Eur Respir J 2003; 22: p. 654–660.
  50. ^ Tepper RS, Skatrud B, Dempsey JA, Ventilation and oxygenation changes during sleep in cystic fibrosis, Chest 1983; 84; p. 388-393.
  51. ^ Browning IB, D'Alonzo GE, Tobin MJ, Importance of respiratory rate as an indicator of respiratory dysfunction in patients with cystic fibrosis, Chest. 1990 Jun;97(6):1317-21.
  52. ^ Ward SA, Tomezsko JL, Holsclaw DS, Paolone AM, Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus, Am J Clin Nutr 1999;69:913–9.
  53. ^ Dodd JD, Barry SC, Gallagher CG, Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease, Respiratory Physiology & Neurobiology 152 (2006) 176–185.
  54. ^ McKone, E.F., Barry, S.C., Fitzgerald, M.X., Gallagher, C.G., The role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis, J Appl Physiol. 2005 Sep; 99(3): 1012-8.
  55. ^ Radwan L, Maszczyk Z, Koziorowski A, Koziej M, Cieslicki J, Sliwinski P, Zielinski J, Control of breathing in obstructive sleep apnea and in patients with the overlap syndrome, Eur Respir J. 1995 Apr; 8(4): p.542-545.
  56. ^ Kahaly GJ, Nieswandt J, Wagner S, Schlegel J, Mohr-Kahaly S, Hommel G, Ineffective cardiorespiratory function in hyperthyroidism, J Clin Endocrinol Metab 1998 Nov; 83(11): 4075-4078.
  57. ^ Esquivel E, Chaussain M, Plouin P, Ponsot G, Arthuis M, Physical exercise and voluntary hyperventilation in childhood absence epilepsy, Electroencephalogr Clin Neurophysiol 1991 Aug; 79(2): 127-132.
  58. ^ Pain MC, Biddle N, Tiller JW, Panic disorder, the ventilatory response to carbon dioxide and respiratory variables, Psychosom Med 1988 Sep-Oct; 50(5): p. 541-548.
  59. ^ MacKinnon DF, Craighead B, Hoehn-Saric R, Carbon dioxide provocation of anxiety and respiratory response in bipolar disorder, J Affect Disord 2007 Apr; 99(1-3): p.45-49.

Artour2006 (talk) 21:09, 15 June 2009 (UTC)

Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Artour2006/Prevalence_of_hyperventilation&oldid=409530946"